View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
29 June, 2021updated 29 Oct 2021 11:13

Oscor to invest $10m in its Dominican Republic manufacturing facilities

US-based medical device company Oscor will add 18,500m2 of clean room manufacturing space in the Dominican Republic and create more than 400 jobs by 2025.

By Naomi Davies

Florida-based Oscor, a manufacturer of highly specialised diagnostic devices, has announced plans to expand its manufacturing facilities in Las Americas Industrial Free Zone Park, Dominican Republic. The company will invest $10m to add 18,500m2 of clean room manufacturing space in two phases by 2025.

The investment will ensure Oscor has leading-edge capabilities in cleanroom assembly, injection moulding, extrusion, laser processing, clean room packaging and sterilisation to support its OEM and contract manufacturing services. The company will also add more than 400 manufacturing employees and is expected to employ over 1,500 people in an area of more than  27,800m2 by 2024.

The new plant will produce implantable pacing and neuromodulation leads, next-generation introducer and guiding sheaths, and high-performance medical components as well as providing contract manufacturing, packaging and sterilisation services for other medical device companies.

Oscor currently operates two US manufacturing plants in Tampa Bay, Florida, two in the Dominican Republic, and sales and distribution offices in Palm Harbor, Florida, and Dusseldorf, Germany.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Data, analysis and deep insights on foreign direct investment delivered to you
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Investment Monitor